Aggrenox®/Asasantin®

The rationale for the development of Aggrenox®/Asasantin® (200 mg extended-release dipyridamole plus 25 mg ASA), the value of its unique formulation, the evidence for its favourable efficacy, recommendations for its use, and its lack of serious side effects are described throughout this section.